Columbia Dividend Opportunity Fund
Columbia Funds Series Trust II · 7 share classes
Fund classification
Classified from what the fund holds · as of 2026 Q2
Columbia Dividend Opportunity Fund is an actively managed U.S. equity fund. 2% of INUTX’s stock holdings are in companies whose revenue grew in the top quartile of U.S. companies over the last five fiscal years (covering 93% of the fund’s equity).
- Asset class
- Equity
- Region
- United States
- Management
- Actively managed
- Fund type
- Open-end fund
Fund profile
As filed in the prospectus · 2025 Q3
Columbia Dividend Opportunity Fund (the Fund) seeks to provide shareholders with a high level of current income.
The fund invests at least 80% of its net assets in dividend-paying common and preferred stocks, selecting securities believed to offer attractive valuations and long-term growth potential across companies of any size. The fund may allocate up to 25% of assets to foreign investments and may emphasize particular sectors, including financials. Because portfolio performance depends on the selection of individual dividend-paying securities, returns will diverge from any broad market benchmark.
| Share class | Expense ratio |
|---|---|
| INUTX | 1.03% |
| ACUIX | 1.78% |
| RSOOX | 1.28% |
| RSDFX | 0.74% |
| CDOZX | 0.78% |
| CDOYX | 0.70% |
| CDOAX | 0.78% |
Portfolio turnover 36.00% · as of 2025 Q3
Allocation
Asset groups · long / short shown separately, never netted · 2026 Q2
| Stocks | 97.77% |
| Cash & short-term | 1.29% |
| Bonds | 0.67% |
Sector allocation
The same holdings as Allocation above, grouped by market sector instead of asset type · as of 2026 Q2
| Financials | 18.0% |
| Information Technology | 14.4% |
| Health Care | 11.4% |
| Industrials | 8.9% |
| 9 smaller | 47.4% |
Government, Securitized and Cash are non-corporate buckets; International is foreign holdings we don’t sector-classify, and Other is the residual (held funds, unresolved names).
Portfolio growth profile
How much of the fund’s stock holdings are in fast-growing companies · as of 2026 Q2
Share of the fund’s equity (by value) in companies whose trailing five-year revenue — or net-income — growth ranks in the top 25% of U.S. public companies. Foreign and newly-listed holdings are excluded, so the figure covers only part of the book. From SEC filings — not investment advice. How we measure this.
Latest quarter
What changed since the fund's previous filing
Return profile
Total return as filed — price change plus distributions reinvested · trailing figures to Apr 2026
| Share class | 1-year | 3-year | 5-year | Vol | Worst fall |
|---|---|---|---|---|---|
| +28.11% | +53.77% | +66.78% | 9.34% | -9.77% | |
| +27.17% | +50.33% | +60.52% | 9.36% | -9.92% | |
| +27.79% | +52.56% | +64.57% | 9.35% | -9.80% | |
| +28.50% | +55.12% | +69.21% | 9.35% | -9.72% | |
| +28.41% | +54.87% | +68.77% | 9.37% | -9.74% | |
| — | — | — | — | — | |
| +28.54% | +55.24% | +69.53% | 9.36% | -9.71% | |
| +28.40% | — | — | 9.36% | — |
May 2026 has been filed since the trailing figures were struck, so it is not in the table above or the curve — every figure here shares one cut-off, which is what makes them comparable with other funds.
Debt profile
What this fund holds — value-weighted across its bond and securitized long positions · as of 2026-05-31
Share of the fund's debt by how its coupon behaves — the fact that decides whether a rate move reaches this portfolio at all.
| Fixed rate | 100.0% |
Share of the fund's debt value in each maturity band, shortest first.
| 3-5y | 100.0% |
Based on what filers reported; a filer that never reported a flag also reads as none.
Holdings
By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page
| Ticker | Issuer | %NAV | Reported price | Value | Shares |
|---|---|---|---|---|---|
| CSCO | Cisco Systems IncCSCO | 3.60% | $120.42 | $88.12M | 731.8K |
| XOM | Exxon Mobil CorpXOM | 3.35% | $145.26 | $82.04M | 564.8K |
| JPM | JPMorgan Chase & CoJPM | 2.91% | $299.31 | $71.36M | 238.4K |
| GS | The Goldman Sachs Group IncGS | 2.80% | $1,025.56 | $68.61M | 66.9K |
| JNJ | Johnson & JohnsonJNJ | 2.60% | $225.33 | $63.72M | 282.8K |
| IBM | International Business Machines CorpIBM | 2.30% | $297.80 | $56.31M | 189.1K |
| PM | Philip Morris International IncPM | 2.17% | $177.38 | $53.20M | 299.9K |
| CVX | Chevron CorpCVX | 2.09% | $182.46 | $51.11M | 280.1K |
| ABBV | AbbVie IncABBV | 1.97% | $217.72 | $48.22M | 221.5K |
| MRK | Merck & Co IncMRK | 1.90% | $118.72 | $46.44M | 391.2K |
Reported price is the fund's own reported value divided by its own reported shares at 2026-05-31 — not a live quote, and not what the fund paid.
Top 10 positions are 25.67% of net assets, top 25 47.47%, across 90 issuers.
See more of this fund's book
More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.
Sign in free